英文名称 | 中文名称 | CAS | MF |
ristotetraose
|
|
128142-69-8
|
C23H40O19
|
Ristocetin A
|
|
37361-31-2
|
C95H110N8O44
|
Teicoplanin A2-4
|
替考拉宁 A2-4
|
91032-37-0
|
C89H99Cl2N9O33
|
Teicoplanin A2-3
|
替考拉宁 A2-3
|
91032-36-9
|
C88H97Cl2N9O33
|
Ristomycin A aglycone, 34-O-2-(acetylamino)-2-deoxy-.beta.-D-glucopyranosyl-22,31-dichloro-7-demethyl-64-O-demethyl-19-deoxy-56-O-2-deoxy-2-(8-methyl-1-oxononyl)amino-.beta.-D-glucopyranosyl-42-O-.alpha.-D-mannopyranosyl-
|
替考拉宁 A2-2
|
91032-26-7
|
C88H97Cl2N9O33
|
Ristomycin A aglycone, 34-O-2-(acetylamino)-2-deoxy-.beta.-D-glucopyranosyl-22,31-dichloro-7-demethyl-64-O-demethyl-19-deoxy-56-O-2-deoxy-2-(10-methyl-1-oxoundecyl)amino-.beta.-D-glucopyranosyl-42-O-.alpha.-D-mannopyranosyl-
|
|
122068-02-4
|
C90H101Cl2N9O33
|
Teicoplanin A2-5
|
替考拉宁 A2-5
|
91032-38-1
|
C89H99Cl2N9O33
|
RITODRINE HYDROCHLORIDE
|
盐酸利托菌
|
4635-27-2
|
C17H21NO3
|
RitodrineHydrochloride(EdmfAvailableInCtdFormat)
|
|
|
|
RITODRINE
|
盐酸利托菌
|
26652-09-5
|
C17H21NO3
|
Ritodrine hydrochloride
|
盐酸利托君
|
23239-51-2
|
C17H22ClNO3
|
Ritolukast
|
利托司特
|
|
|
RIT-O-LITE MHP
|
|
|
|
RITONAVIR
|
|
162990-01-4
|
C37H48N6O5S2
|
Ritonavir
|
利托那韦
|
155213-67-5
|
C37H48N6O5S2
|
Ritonavir
|
|
|
|
RITONAVIR [3H(G)]
|
|
|
C37N6O5S2T48
|
RITONAVIR, [3H]-
|
|
|
C37N6O5S2T48
|
Ritonavir Related Compounds Mixture
|
雷米普利杂质混合物
|
|
|
Ritonavir for peak identfication
|
|
|
|
Ritonavir-13C3
|
|
|
C37H48N6O5S2
|
RITONAVIR-D6
|
雷托那韦D6
|
1217720-20-1
|
C37H42D6N6O5S2
|
Rit protein, mouse
|
|
|
|
Ritropirronium
|
格隆溴铵
|
53808-86-9
|
C19H28BrNO3
|
Ritrosulfan
|
利曲舒凡
|
4148-16-7
|
C10H24N2O8S2
|
rivaloside A
|
|
|
|
rivaloside B
|
|
|
|
rivanicline
|
(E)-位变异烟碱
|
15585-43-0
|
C10H14N2
|
Rivaroxaban Hydroxyoxazalone Metabolite
(Mixture of Diastereomers)
|
利伐沙班4-羟基代谢物
|
1161719-51-2
|
C19H18ClN3O6S
|
Rivaroxaban-d4
|
5-氯-N-[[(5S)-2-氧代-3-[4-(3-氧代-4-吗啉基)苯基-2,3,5,6-D4]-5-恶唑烷基]甲基]-2-噻吩甲酰胺
|
1132681-38-9
|
C19H18ClN3O5S
|
Rivaroxaban Diol (Mixture of Diastereomers)
|
利伐沙班二醇
|
1160170-00-2
|
C19H20ClN3O6S
|
RK-BARF0 protein
|
|
|
|
Rivaroxaban
|
利伐沙班
|
366789-02-8
|
C19H18ClN3O5S
|
Rivastigmine Tartrate R-Isomer (20 mg) ((R)-3-[1-(Dimethylamino)ethyl]phenyl ethylmethylcarbamate, hydrogen tartrate)
|
|
|
|
(R,S)-3-[1-(Dimethylamino)ethyl]phenyl dimethylcarbamate
|
酒石酸卡巴拉汀杂质B
|
25081-93-0
|
C13H20N2O2
|
RIVASTIGMINE
|
乙基(甲基)氨基甲酸[3-[1-(二甲氨基)乙基]苯基]酯
|
105601-20-5
|
C14H22N2O2
|
RivastigmineTartarate
|
|
|
|
Rivastigmin
|
RIVASTIGMIN
|
|
|
RIVASTIGMINE, [3H(G)]
|
|
|
C14N2O2T22
|
Rivastigmine tartrate
|
酒石酸卡巴拉汀
|
129101-54-8
|
C18H28N2O8
|
RIVASTIGMINE-D6 TARTRATE (RACEMIC)
|
|
|
C18H22D6N2O8
|
Rivastigmine
|
卡巴拉汀
|
123441-03-2
|
C14H22N2O2
|
RivastigmineHydrogenTartarate
|
|
|
|
Rivastigmine12
|
|
3441-03-2
|
|
Rituximab
|
利妥昔单抗
|
|
|
Rituximab
|
利妥昔单抗
|
174722-31-7
|
C6416H9874N1688O1987S44
|
RIVELLABLUE
|
|
|
|
rivenprost
|
rivenprost
|
256382-08-8
|
C24H34O6S
|
River SediMent Sol A in 4 Percent HNO3
|
|
|
|
River SediMent Sol B in 4 Percent HNO3
|
|
|
|
Riverclay - Organic compounds, inorganic composition (please ask for detailed information)
|
|
|
|
River water - Major ions and nutrients
|
|
|
|
River water - Trace elements
|
|
|
|
River sediment - Extractable metals
|
|
|
|
River sediment - Phosphorous
|
|
|
|
Riverclay - Inorganic composition (please ask for detailed information)
|
|
|
|
River sediment - PAHs
|
|
|
|
River sediment (bioavailable phosphorus)
|
河流沉积物(生物可利用磷)
|
|
|
RIVER WATER 2 VKI STANDARD
|
|
|
|
RIVER SEDIMENT
|
|
|
|
RIVER WATER 1 VKI STANDARD
|
|
|
|
RkappaB protein
|
|
|
|
rivicycline
|
|
130030-59-0
|
C94H119ClN14O27S
|
[16R,(-)]-Kaurane-3α,17,18-triol
|
|
|
|
(5α,8β,9α,10β,13β,16R)-Kauran-15-one
|
|
|
|
(16R)-Kaur-11-ene-7β,16-diol 7-acetate
|
|
|
|
(4R)-Kaura-16-ene-19-ol
|
|
|
|
[16R,(-)]-Kaurane-3α,16α,17,18-tetrol
|
|
|
|
[16R,(-)]-Kaurane-3α,16α,18-triol
|
|
|
|
[16R,(-)]-Kaurane-3α,16α,17-triol
|
|
|
|
(16R)-Kaurane-17,18-dioic acid
|
|
|
|
(16R)-Kaur-11-ene-7β,16-diol
|
|
|
|
[16R,(-)]-Kaurane-16α,17,18-triol
|
|
|
|
[16R,(-)]-Kaurane-17,18-diol
|
|
|
|
[16R,(-)]-Kaurane-6β,16α,17-triol
|
贝壳杉烷-6BETA,16,17-三醇
|
7047-54-3
|
C20H34O3
|
(5α,9α,10β,16R)-Kauran-16-ol
|
|
27898-42-6
|
C20H34O
|
RIVOGLITAZONE
|
RIVOGLITAZONE
|
185428-18-6
|
C20H19N3O4S
|
RK 286D
|
化合物 T26098
|
140429-37-4
|
C26H23N3O4
|
Rivulobirin B
|
9-羟基-4-[(4-甲氧基-7-氧代-7H-呋喃并[3,2-G][1]苯并吡喃-9-基)氧基]-7H-呋喃并[3,2-G][1]苯并吡喃-7-酮
|
194145-29-4
|
C23H12O9
|
Rivulobirin E
|
RIVULOBIRIN E
|
237407-59-9
|
C32H30O11
|
R4K conjugate
|
|
|
|
RIX7 protein
|
|
|
|
Rizatriptan N10-Oxide-d6
|
Rizatriptan N10-Oxide-d6
|
1261392-57-7
|
C15H18N5O
|
Rizatriptan 2,2-DiMer
|
利扎曲普坦二聚物
|
1135479-44-5
|
C36H49N11
|
Rizatriptan Benzoate System Suitability Mixture (15 mg)
|
Rizatriptan Benzoate System Suitability Mixture (15 mg)
|
|
|
Rizatriptan IMpurity B
|
利扎曲普坦杂质B
|
1016900-28-9
|
C13H15ClN5
|
Rizatriptan IMpurity A
|
利扎曲普坦杂质A
|
1391062-45-5
|
C20H25N5O5
|
Rizatriptan DiMer Benzoate
|
2-[[3-[2-(二甲基氨基)乙基]-1H-吲哚-5-基]甲基]-N,N-二甲基-5-(1H-1,2,4-三唑-1-基甲基)-1H-吲哚-3-乙胺苯甲酸盐
|
1016900-25-6
|
C35H41N7O2
|
Rizatriptan
|
利扎曲坦
|
144034-80-0
|
C15H19N5
|
RIZATRIPTAN-D6
|
RIZATRIPTAN-D6
|
606927-07-5
|
C15H13D6N5
|
Rizatriptan benzoate
|
苯甲酸利扎曲坦
|
145202-66-0
|
C22H25N5O2
|
Rizatriptan-d6 Benzoate
|
Rizatriptan-d6 Benzoate
|
1216984-85-8
|
C22H24N5O2
|
Rizatriptan4-[1,2,4-Triazole-1-Yl]MethylPhenylHydrazineHcl
|
|
|
|
Rizatriptan Benzoate Intermediate
|
|
|
|
Rizatriptan N10-Oxide
|
利扎曲普坦N氧化物
|
260435-42-5
|
C15H19N5O
|
Rizatraptan
|
|
|
|
Rizatriptan N-oxide
|
利扎曲普坦N氧化物
|
|
C15H19N5O
|
(R)-(-)-Ketoprofen-13C,d3
|
(R)-(-)-KETOPROFEN-13C,D3
|
1329496-52-7
|
C16H11D3O3
|
(R)-Ketoprofen Acyl-β-D-glucuronide
|
(R)-Ketoprofen Acyl-β-D-glucuronide
|
140148-25-0
|
C22H22O9
|
(R)-(+)-Ketorolac
|
(1R)-5-苯基-2,3-二氢-1H-吡啶-1-羧酸
|
66635-93-6
|
C15H13NO3
|